Content Maintained by Language
- Page Views 19187
CITI Program will streamline content maintained in varying languages to enhance the quality of translated content. You will have unlimited access to translated content for a fee of $500 per site, per language, in addition to your organization’s base subscription. This change went into effect on 1 June 2019. For languages not included below, please get in touch with Sales at sales@citiprogram.org for a custom quote.
The list below is separated by language and course and displays the English title of translated modules. The ID number is for the translation.
Note: This list of translated modules is always under review. Please bookmark this page and check back periodically for new updates.
If your organization’s translated content is not listed below, schedule a consultation to review the options available.

Spanish
Human Subjects Research - Social-Behavioral-Educational (SBE) Basic Modules
History and Ethical Principles – SBE (ID: 16460)
Defining Research with Human Subjects – SBE (ID: 16461)
The Federal Regulations – SBE (ID: 16462)
Assessing Risk – SBE (ID: 16463)
Informed Consent – SBE (ID: 16464)
Privacy and Confidentiality – SBE (ID: 16465)
Research with Children – SBE (ID: 16466)
International Research – SBE (ID: 16467)
Internet-Based Research – SBE (ID: 16468)
Unanticipated Problems and Reporting Requirements in Social and Behavioral Research (ID: 16469)
Populations in Research Requiring Additional Considerations and/or Protections (ID: 19563)
Students in Research (ID: 1671)
Human Subjects Research - Biomedical (Biomed) Basic Modules
Basic Institutional Review Board (IRB) Regulations and Review Process (ID: 1479)
Informed consent (ID: 1480)
Social and Behavioral Research (SBR) for Biomedical Researchers (ID: 1718)
Record-based research (ID: 1490)
Genetic Research in Human Populations (ID: 1672)
Research Involving Prisoners (ID: 1482)
Research Involving Children (ID: 1498)
Research Involving Pregnant Women, Fetuses, and Neonates (ID: 1499)
FDA-Regulated Research (ID: 1493)
Research and HIPAA Privacy Protections (ID: 15448)
History and Ethics of Human Subjects Research (ID: 1478)
International Studies (ID: 1481)
Students in Research (ID: 1671)
Avoiding Group Harms - U.S. Research Perspectives (ID: 1719)
Populations in Research Requiring Additional Considerations and/or Protections (ID: 19563)
Revised Common Rule
Overview of the Final Rule Revisions (ID: 19362)
New and Revised Definitions (ID: 19363)
Informed Consent – Changes and Additions to Consent Processes (ID: 19364)
Informed Consent – Changes to the Documentation of Consent (ID: 19365)
Understanding Broad Consent (ID: 19366)
Secondary Research with Identifiable Information and Biospecimens (ID: 19367)
Effect of Revised Common Rule on Research Roles (ID: 19368)
Updates to Exemption Categories (ID: 19369)
Limited IRB Review (ID: 19370)
Updates to Expedited Review Procedures (ID: 19371)
GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus)
The CITI Good Clinical Practice Course for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus) (ID: 12149)
Overview of New Drug Development (ID: 12159)
Overview of ICH GCP (ID: 12720)
ICH – Comparison Between ICH GCP E6 and U.S. FDA Regulations (ID: 12153)
Conducting Investigator-Initiated Studies According to FDA Regulations and GCP (ID: 12154)
Investigator Obligations in FDA-Regulated Clinical Research (ID: 12155)
Managing Investigational Agents According to GCP Requirements (ID: 12156)
Overview of U.S. FDA Regulations for Medical Devices (ID: 12151)
Informed Consent in Clinical Trials of Drugs, Biologics, and Devices (ID: 12194)
Detecting and Evaluating Adverse Events (ID: 12152)
Reporting Serious Adverse Events (ID: 12158)
Monitoring of Clinical Trials by Industry Sponsors (ID: 12157)
Audits and Inspections of Clinical Trials (ID: 12150)
Completing the CITI GCP Course (ID: 12161)
GCP for Clinical Investigations of Devices
Conducting Investigator-Initiated Clinical Investigations of Devices (ID: 15287)
Investigator Obligations in FDA-Regulated Clinical Investigations of Devices (ID: 15288)
Managing Investigational Devices According to GCP Requirements (ID: 15289)
Overview of U.S. FDA Regulations for Investigational Devices (ID: 15290)
Informed Consent in Clinical Investigations of Devices (ID: 15291)
Monitoring Clinical Investigations of Devices (ID: 15292)
Audits and Inspections in Clinical Trials of Devices (ID: 15293)
Reporting Requirements for Clinical Investigations of Devices (ID: 15294)
Completing the CITI Program’s GCP Course for Clinical Investigations of Devices (ID: 15295)
GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
GCP Introduction (ID: 15273)
Conducting Investigator-Initiated Studies According to FDA Regulations and GCP (ID: 15274)
Investigator Obligations in FDA-Regulated Research (ID: 15275)
Managing Investigational Agents According to GCP Requirements (ID: 15276)
Informed Consent in Clinical Trials of Drugs and Biologics (ID: 15277)
Monitoring of Clinical Trials of Drugs by Industry Sponsors (ID: 15278)
Audits and Inspections of Clinical Trials of Drugs and Biologics (ID: 15279)
Overview of New Drug Development (ID: 15280)
ICH Overview (ID: 15281)
Detection and Evaluation of Adverse Events (ID: 15283)
Reporting Serious Adverse Events in Investigations of Drugs and Biologics (ID: 15284)
ICH - Comparison Between ICH GCP E6 and U.S. FDA Regulations (ID: 15282)
Completing the CITI GCP Course (ID: 15285)
GCP Device Refresher
GCP Refresher - Conducting Clinical Investigations of Devices (ID: 17362)
GCP Refresher - Review of U.S. FDA Regulations for Investigational Devices (ID: 17363)
GCP Refresher - Additional GCP Standards for International Clinical Investigations of Devices (ID: 17364)
GCP Refresher - Informed Consent and Exceptions to the Requirement for Obtaining Consent for Clinical Investigations of Devices (ID: 17365)
GCP Refresher - Oversight of Clinical Investigations of Devices (ID: 17366)
GCP Refresher - Reporting Requirements for Clinical Investigations of Devices (ID: 17367)
GCP ICH Refresher
GCP Refresher - International Conference on Harmonisation (ICH): GCP Requirements (ID: 17371)
GCP Refresher - Investigator's Responsibilities and GCP (ID: 17372)
GCP Refresher - Informed Consent (ID: 17373)
GCP Refresher - Safety Management (ID: 17374)
GCP Refresher - Investigational Product (Drug) Management (ID: 17375)
GCP Refresher - Audits, Inspection, and Monitoring of Research Studies (ID: 17376)
GCP Refresher - Sponsor Responsibilities and GCP (ID: 17377)
Responsible Conduct of Research (BASIC)
Authorship (RCR-Basic) (ID: 20790)
Collaborative Research (RCR-Basic) (ID: 20791)
Conflicts of Interest (RCR-Basic) (ID: 20792)
Data Management (RCR-Basic) (ID: 20793)
Financial Responsibility (RCR-Basic) (ID: 20794)
Mentoring (RCR-Basic) (ID: 20795)
Peer Review (RCR-Basic) (ID: 20796)
Research Misconduct (RCR-Basic) (ID: 20797)
Introduction to RCR (RCR-Basic) (ID: 20798)
Reproducibility of Research Results (RCR-Basic) (ID: 20799)
Communicating with the Public (RCR-Basic) (ID: 20800)
Presentation of Research Findings (RCR-Basic) (ID: 20801)
Plagiarism (RCR-Basic) (ID: 20802)
Communicating Research Findings
Communicating with the Public (ID: 20800)
Presentation of Research Findings (ID: 20801)
General Laboratory Safety for Non-Laboratory Personnel
Hazard Awareness (ID: 20740)
Safe Work Practices (ID: 20741)
Emergency Situations (ID: 20742)

Simplified Chinese*
GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
The CITI Good Clinical Practice Course for Clinical Trials Involving Drugs and Biologics (ID: 19605)
Overview of New Drug Development (ID: 19606)
Overview of ICH GCP (ID: 19607)
ICH—Comparison Between ICH GCP E6 and U.S. FDA Regulations (ID: 19608)
Conducting Investigator-Initiated Studies According to FDA Regulations and GCP (ID: 19609)
Investigator Obligations in FDA-Regulated Research (ID: 19610)
Managing Investigational Agents According to GCP Requirements (ID: 19611)
Informed Consent in Clinical Trials of Drugs and Biologics (ID: 19612)
Monitoring Clinical Trials of Drugs by Industry Sponsors (ID: 19613)
Audits and Inspections of Clinical Trials of Drugs and Biologics (ID: 19614)
Detecting and Evaluating Adverse Events (ID: 19615)
Reporting Serious Adverse Events in Investigations of Drugs and Biologics (ID: 19616)
Completing the CITI GCP Course (ID: 19617)
GCP for Clinical Investigations of Devices
The CITI Good Clinical Practice Course for Clinical Investigations of Devices (ID: 19786)
Overview of U.S. FDA Regulations for Investigational Devices (ID: 19787)
Investigator Obligations in FDA-Regulated Clinical Investigations of Devices (ID: 19788)
Conducting Investigator-Initiated Clinical Investigations of Devices (ID: 19789)
Managing Investigational Devices According to GCP Requirements (ID: 19790)
Informed Consent in Clinical Investigations of Devices (ID: 19791)
Monitoring Clinical Investigations of Devices (ID: 19792)
Audits and Inspections of Clinical Investigations of Devices (ID: 19793)
Reporting Requirements for Clinical Investigations of Devices (ID: 19794)
Completing the CITI Program’s GCP Course for Clinical Investigations of Devices (ID: 19795)
GCP Device Refresher
GCP Refresher - Conducting Clinical Investigations of Devices (ID: 19850)
GCP Refresher - Review of U.S. FDA Regulations for Investigational Devices (ID: 19851)
GCP Refresher - Additional GCP Standards for International Clinical Investigations of Devices (ID: 19852)
GCP Refresher - Informed Consent and Exceptions to the Requirement for Obtaining Consent for Clinical Investigations of Devices (ID: 19853)
GCP Refresher - Oversight of Clinical Investigations of Devices (ID: 19854)
GCP Refresher - Reporting Requirements for Clinical Investigations of Devices (ID: 19855)

French
Human Subjects Research - Social-Behavioral-Educational (SBE) Basic Modules
History and Ethical Principles – SBE (ID: 16449)
Defining Research with Human Subjects – SBE (ID: 16450)
The Regulations – SBE (ID: 16451)
Assessing Risk – SBE (ID: 16452)
Informed Consent – SBE (ID: 16453)
Privacy and Confidentiality – SBE (ID: 16454)
Research with Children – SBE (ID: 16455)
International Research – SBE (ID: 16456)
Internet Research – SBE (ID: 16457)
Unanticipated Problems and Reporting Requirements in Social and Behavioral Research (ID: 16458)
Populations in Research Requiring Additional Considerations and/or Protections (ID: 19566)
GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
The CITI Good Clinical Practice Course for Clinical Investigations of Devices (ID: 19776)
Overview of U.S. FDA Regulations for Investigational Devices (ID: 19777)
Investigator Obligations in FDA-Regulated Clinical Investigations of Devices (ID: 19778)
Conducting Investigator-Initiated Clinical Investigations of Devices (ID: 19779)
Managing Investigational Devices According to GCP Requirements (ID: 19780)
Informed Consent in Clinical Investigations of Devices (ID: 19781)
Monitoring Clinical Investigations of Devices (ID: 19782)
Audits and Inspections of Clinical Investigations of Devices (ID: 19783)
Reporting Requirements for Clinical Investigations of Devices (ID: 19784)
Completing the CITI Program’s GCP Course for Clinical Investigations of Devices (ID: 19785)
GCP Device Refresher
GCP Refresher - Conducting Clinical Investigations of Devices (ID: 19844)
GCP Refresher - Review of U.S. FDA Regulations for Investigational Devices (ID: 19845)
GCP Refresher - Additional GCP Standards for International Clinical Investigations of Devices (ID: 19846)
GCP Refresher - Informed Consent and Exceptions to the Requirement for Obtaining Consent for Clinical Investigations of Devices (ID: 19847)
GCP Refresher - Oversight of Clinical Investigations of Devices (ID: 19848)
GCP Refresher - Reporting Requirements for Clinical Investigations of Devices (ID: 19849)
Responsible Conduct of Research (RCR) Basic
Introduction to RCR (RCR-Basic) (ID: 21341)
Authorship (RCR-Basic) (ID: 21342)
Collaborative Research (RCR-Basic) (ID: 21343)
Conflicts of Interest (RCR-Basic) (ID: 21344)
Data Management (RCR-Basic) (ID: 21345)
Mentoring (RCR-Basic) (ID: 21346)
Peer Review (RCR-Basic) (ID: 21347)
Reproducibility of Research Results (RCR-Basic) (ID: 21348)
Research Misconduct (RCR-Basic) (ID: 21349)
Financial Responsibility (RCR-Basic) (ID: 21350)
Communicating with the Public (RCR-Basic) (ID: 21351)
Presentation of Research Findings (RCR-Basic) (ID: 21352)
Environmental and Social Dimensions of Engineering Research (RCR-Basic) (ID: 21353)
Using Animal Subjects in Research (RCR-Basic) (ID: 21354)
Research Involving Human Subjects (RCR-Basic) (ID: 21355)
Plagiarism (RCR-Basic) (ID: 21356)
Research, Ethics, and Society (RCR-Basic) (ID: 21357)
Responsible Conduct of Research (RCR) Refresher
Authorship (RCR-Refresher) (ID: 21312)
Collaborative Research (RCR-Refresher) (ID: 21313)
Conflicts of Interest (RCR-Refresher) (ID: 21314)
Data Management (RCR-Refresher) (ID: 21315)
Mentoring (RCR-Refresher) (ID: 21316)
Peer Review (RCR-Refresher) (ID: 21317)
Plagiarism (RCR-Refresher) (ID: 21318)
Research Involving Human Subjects (RCR-Refresher) (ID: 21319)
Using Animal Subjects in Research (RCR-Refresher) (ID: 21320)
Research Misconduct (RCR-Refresher) (ID: 21321)

German
GCP for Clinical Investigations of Devices
The CITI Good Clinical Practice Course for Clinical Investigations of Devices (ID: 19796)
Overview of U.S. FDA Regulations for Investigational Devices (ID: 19797)
Investigator Obligations in FDA-Regulated Clinical Investigations of Devices (ID: 19798)
Conducting Investigator-Initiated Clinical Investigations of Devices (ID: 19799)
Managing Investigational Devices According to GCP Requirements (ID: 19800)
Informed Consent in Clinical Investigations of Devices (ID: 19801)
Monitoring Clinical Investigations of Devices (ID: 19802)
Audits and Inspections of Clinical Investigations of Devices (ID: 19803)
Reporting Requirements for Clinical Investigations of Devices (ID: 19804)
Completing the CITI Program’s GCP Course for Clinical Investigations of Devices (ID: 19805)
GCP Device Refresher
GCP Refresher - Conducting Clinical Investigations of Devices (ID: 19856)
GCP Refresher - Review of U.S. FDA Regulations for Investigational Devices (ID: 19857)
GCP Refresher - Additional GCP Standards for International Clinical Investigations of Devices (ID: 19858)
GCP Refresher - Informed Consent and Exceptions to the Requirement for Obtaining Consent for Clinical Investigations of Devices (ID: 19859)
GCP Refresher - Oversight of Clinical Investigations of Devices (ID: 19860)
GCP Refresher - Reporting Requirements for Clinical Investigations of Devices (ID: 19861)

Finnish
GCP for Clinical Investigations of Devices
The CITI Good Clinical Practice Course for Clinical Investigations of Devices (ID: 19766)
Overview of U.S. FDA Regulations for Investigational Devices (ID: 19767)
Investigator Obligations in FDA-Regulated Clinical Investigations of Devices (ID: 19768)
Conducting Investigator-Initiated Clinical Investigations of Devices (ID: 19769)
Managing Investigational Devices According to GCP Requirements (ID: 19770)
Informed Consent in Clinical Investigations of Devices (ID: 19771)
Monitoring Clinical Investigations of Devices (ID: 19772)
Audits and Inspections of Clinical Investigations of Devices (ID: 19773)
Reporting Requirements for Clinical Investigations of Devices (ID: 19774)
Completing the CITI Program’s GCP Course for Clinical Investigations of Devices (ID: 19775)
GCP Refresher - Conducting Clinical Investigations of Devices (ID: 19838)
GCP Refresher - Review of U.S. FDA Regulations for Investigational Devices (ID: 19839)
GCP Refresher - Additional GCP Standards for International Clinical Investigations of Devices (ID: 19840)
GCP Refresher - Informed Consent and Exceptions to the Requirement for Obtaining Consent for Clinical Investigations of Devices (ID: 19841)
GCP Refresher - Oversight of Clinical Investigations of Devices (ID: 19842)
GCP Refresher - Reporting Requirements for Clinical Investigations of Devices (ID: 19843)
Vietnamese
Human Subjects Research - Social-Behavioral-Educational (SBE) Basic Modules
Defining Research with Human Subjects - SBE (ID: 16111)
Assessing Risk - SBE (ID: 16112)
Privacy and Confidentiality - SBE (ID: 16113)
Internet Research - SBE (ID: 16114)
Human Subjects Research - Biomedical (Biomed) Basic Modules
Basic Institutional Review Board IRB Regulations and Review Process (ID: 15884)
Informed Consent (ID: 15885)
Social and Behavioral Research SBR for Biomedical Researchers (ID: 15886)
Genetic Research in Human Populations (ID: 15887)
FDA-Regulated Research (ID: 15889)
Avoiding Group Harms - U.S. Research Perspectives (ID: 16118)
Records-Based Research (ID: 16242)
Vulnerable Subjects - Research Involving Prisoners (ID: 16550)
Vulnerable Subjects - Research Involving Children (ID: 16551)
Vulnerable Subjects - Research Involving Pregnant Women, Human Fetuses, and Neonates (ID: 16552)
Avoiding Group Harms - International Research Perspectives (ID: 16554)
Recognizing and Reporting Unanticipated Problems Involving Risks to Subjects or Others in Biomedical Research (ID: 16555)
Populations in Research Requiring Additional Considerations and/or Protections (ID: 19568)
Defining Research with Human Subjects - SBE (ID: 16111)
Assessing Risk - SBE (ID: 16112)
Privacy and Confidentiality - SBE (ID: 16113)
Internet Research - SBE (ID: 16114)
*It is important to understand what these terms refer to. Mandarin and Cantonese are the two most common verbal Chinese dialects. But when it comes to writing, you need to distinguish between Simplified and Traditional Chinese instead. The interesting thing is that not everybody who speaks Mandarin writes in Simplified Chinese and not everybody who speaks Cantonese writes in Traditional Chinese. The table above solves the riddle: In P.R. China and Singapore, Mandarin is the spoken language and people resort to Simplified Chinese when they write. In Hong Kong and Macao, Cantonese is the predominant dialect while people write in Traditional Chinese. The exception is Taiwan where people speak Mandarin and write in Traditional Chinese.
|
Country/region |
P.R. China |
Taiwan |
Hong Kong and Macao |
Singapore |
Oversea Chinese community in the U.S. |
|
Written |
Simplified Chinese |
Traditional Chinese |
Traditional Chinese |
Simplified Chinese |
Traditional Chinese is still the predominant format as most Chinese people can read it. |
|
Spoken |
Mandarin |
Mandarin |
Cantonese |
Mandarin |
Mandarin or Cantonese depending on people’s origin, Mandarin is more popular nowdays. |
History and Ethical Principles - SBR (ID: 16449)
Defining Research with Human Subjects - SBR (ID: 16450)
The Regulations and The Social and Behavioral Sciences - SBR (ID: 16451)
Assessing Risk in Social and Behavioral Sciences -SBR (ID: 16452)
Informed Consent - SBR (ID: 16453)
Privacy and Confidentiality (SBR ID: 16454)
Research with Children (SBR ID: 16455)
International Research (SBR ID: 16456)
Internet Research - SBR ID: 16457)
Unanticipated Problems and Reporting Requirements in Social and Behavioral Research (ID: 16458)
Research With Protected Populations - Vulnerable Subjects: An Overview (ID: 16447)